Switching course, Gilead markets HIV drug for prevention

NEW YORK, Nov 30 (Reuters) - Gilead Sciences Inc

has begun marketing its HIV treatment Truvada in a way thousands

of consumers already use it - to prevent infection with the

virus that causes AIDS.

Read more